Grants per year
- 1 - 25 out of 384 results
Search results
-
Active
Prot #M24-064: AndroMETa-CRC-064: An Open Label, Randomized, Controlled, Global Phase 3 Study Comparing ABBV-400 Monotherapy to LONSURF (Trifluridine and Tipiracil) plus Bevacizumab in Subjects with c-Met Over-Expressed Refractory Metastatic Colorectal Ca
Benson III, A. B. (PD/PI)
11/6/24 → 11/6/27
Project: Research project
-
Overcoming Resistance in Synovial Sarcoma to Interferon Gamma Mediated Immuno-sensitization
Pollack, S. M. (PD/PI), Chen, R. (Co-Investigator) & Obeidin, F. (Co-Investigator)
U.S. Army Medical Research and Materiel Command
11/1/24 → 10/31/27
Project: Research project
-
Prot #DS7300-189: A Phase 1b/2, Multicenter, Open-Label Study of Ifinatamab Deruxtecan (I-DXd), A B7H3 Antibody-Drug Conjugate (ADC), in Combination with Atezolizumab with or without Carboplatin as First-Line Induction or Maintenance, in Subjects with Ext
Patel, J. D. (PD/PI)
Quintiles, Inc., Daiichi Sankyo, Inc.
10/25/24 → 10/25/27
Project: Research project
-
Prot #NU 23S02: An Analysis of Nectin‐4 Expression in Soft Tissue Sarcoma
Pollack, S. M. (PD/PI)
Astellas Pharma Global Development, Inc.
10/21/24 → 4/21/26
Project: Research project
-
Prot #CNST0610C210: An Open-Label, Multicenter, Extension Study for Patients Previously Enrolled in Studies With Pelabresib
Stein, B. L. (PD/PI)
Novotech Clinical Research USA, LLC, Constellation Pharmaceuticals, Inc.
10/16/24 → 10/16/27
Project: Research project
-
Understanding Anaphylaxis to Platinum-Based Cancer Chemotherapy and Rapid Drug Desensitization that Enables its Use in Allergic Patients
Stevens, W. (PD/PI), Berin, C. (Other), Bochner, B. S. (Other), Kircher, S. M. (Other) & Roque, D. R. (Other)
American Academy of Allergy, Asthma and Immunology
10/1/24 → 9/30/25
Project: Research project
-
Prot #CRDF-004: A Phase 2, Randomized, Open-label Study of Onvansertib in Combination with FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-line Treatment of Metastatic Colorectal Cancer
Benson III, A. B. (PD/PI)
Pfizer Inc., Cardiff Oncology, Inc.
10/1/24 → 10/1/25
Project: Research project
-
Prot #IMC-F106C-301: A Phase 3 Randomized, Controlled Study of IMC-F106C Plus Nivolumab Versus Nivolumab Regimens in HLA-A*02:01-Positive Participants With Previously Untreated Advanced Melanoma (PRISM-MEL-301)
Chandra, S. (PD/PI)
Worldwide Clinical Trials, Inc., Immunocore Limited
9/30/24 → 9/30/27
Project: Research project
-
Single-cell tracking of the transformation of lung adenocarcinoma to small cell lung cancer
Abazeed, M. (PD/PI), Gopal, P. (Co-Investigator) & Patel, J. D. (Co-Investigator)
U.S. Army Medical Research and Materiel Command
9/30/24 → 9/29/27
Project: Research project
-
Prot #BGB-11417-203: An Open-Label, Multicenter Phase 2 Study to Evaluate the Efficacy and Safety of the BCL2 Inhibitor Sonrotoclax (BGB-11417) as Monotherapy and in Combination with Zanubrutinib (BGB-3111) in Patients With Waldenström Macroglobulinemia
Ma, S. (PD/PI)
9/27/24 → 9/27/27
Project: Research project
-
Prot #NU 23H05: Phase II, Single arm, Open label, study of the combination of Pembrolizumab and Tazemetostat to Overcome Immune Tolerance Following Autologous Stem Cell Transplantation (ASCT) or Chimeric Antigen Receptor (CAR) T-cell therapy in Patients
Karmali, R. (PD/PI)
9/23/24 → 9/23/27
Project: Research project
-
Clinical and Immunological Impact of Interleukin-6 Inhibition on Combination Immunotherapy Efficacy and Toxicity for Patients with Advanced Melanoma
Patel, J. D. (PD/PI)
9/1/24 → 8/31/25
Project: Research project
-
Transforming health at the intersection of implementation science, learning health systems, and genomics at Northwestern Medicine
Beidas, R. S. (PD/PI), Franklin, P. D. (PD/PI), Godley, L. A. (PD/PI), McNally, E. M. (PD/PI), Ahmad, F. S. (Co-Investigator), Bass, M. (Co-Investigator), Beach, L. B. (Co-Investigator), Becker, S. (Co-Investigator), Bradley, C. D. (Co-Investigator), Chisholm, R. L. (Co-Investigator), Chorniy, A. (Co-Investigator), Holmes, K. (Co-Investigator), Rasmussen-Torvik, L. J. (Co-Investigator), Rini, C. (Co-Investigator), Scott, K. (Co-Investigator), Skolarus, L. E. (Co-Investigator), Walunas, T. L. (Co-Investigator) & Young, J. L. (Co-Investigator)
National Human Genome Research Institute
9/1/24 → 12/31/24
Project: Research project
-
Prot #CL3-95031-007: A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Ivosidenib in Participants ≥18 Years of Age with Locally Advanced or Metastatic Conventional Chondrosarcoma with an IDH1 Mutation, Untreated or Previously
Hermida de Viveiros, P. A. (PD/PI)
Quintiles, Inc., Servier Bio-Innovation LLC
8/23/24 → 8/23/31
Project: Research project
-
Enhancing Bispecific Antibody Therapy with Nanoparticle-Based Photothermal Therapy
Lin, A. Y. (PD/PI), Balyasnikova, I. V. (Co-Investigator), Gordon, L. I. (Co-Investigator) & Miller, S. D. (Co-Investigator)
U.S. Army Medical Research and Materiel Command
8/15/24 → 8/14/26
Project: Research project
-
Prot #CF33-CD19-101: A Phase I, Dose Escalation and Dose Expansion, Safety and Tolerability Study of onCARlytics (CF33-CD19), Administered Intravenously or Intratumorally in Combination with Blinatumomab in Adults with Advanced or Metastatic Solid Tumor
Mahalingam, D. (PD/PI)
Medpace Clinical Research LLC, Imugene Limited
8/9/24 → 8/9/27
Project: Research project
-
Development of a DISE-inducing, short RNA therapeutic to treat solid cancers
Peter, M. E. (PD/PI), Bartom, E. T. (Co-Investigator), Kocherginsky, M. (Co-Investigator) & Murmann, A. E. (Co-Investigator)
8/1/24 → 7/31/25
Project: Research project
-
Local nano-immune modulation for the systemic treatment of lymphoma
Lin, A. Y. (PD/PI)
8/1/24 → 7/31/29
Project: Research project
-
Mosaic: RCT of a Digital Health Intervention Delivering Peer Support Narratives and Psychoeducation to English- and Spanish-Speaking Stem Cell Transplant Recipients
Rini, C. (PD/PI), Moreira, J. (Co-Investigator) & Yanez, B. R. (Co-Investigator)
8/1/24 → 7/31/29
Project: Research project
-
Prot #ALE.C04.01: A Phase I/II, Open-Label, Multi-Center Study of ALE.C04 (anti-Claudin-1Antibody) as a Single Agent and in Combination with Pembrolizumab (anti-PD-1 antibody) in Adult Patients with Recurrent or Metastatic (R/M) Head and Neck Squamous Cel
Lorch, J.H.-M. (PD/PI)
Ergomed Clinical Research Inc., Alentis Therapeutics AG
7/19/24 → 7/19/27
Project: Research project
-
Prot #GO44145: A Phase III, Multicenter, Randomized, Open-Label Study Comparing The Efficacy and Safety of Glofitamab (RO7082859) in Combination with Polatuzumab Vedotin Plus Rituximab, Cyclophospamide, Doxorubicin, and Prednisone (POLA-R-CHP) Versus POLA
Karmali, R. (PD/PI)
7/18/24 → 5/31/29
Project: Research project
-
Prot #BLU-285-1406: Observational Study Evaluating the Long-Term Safety and Efficacy of Avapritinib in the First-Line Treatment of Patients with Platelet-Derived Growth Factor Receptor Alpha (PDGFRA) D842V-Mutated Gastrointestinal Stromal Tumour (GIST)
Pollack, S. M. (PD/PI)
INC Research, LLC, Blueprint Medicines Corporation
7/17/24 → 7/17/27
Project: Research project
-
Prot #EQ-100-02: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Multicenter Study of Itolizumab in Combination with Corticosteroids for the Initial Treatment of Acute Graft Versus Host Disease
Moreira, J. (PD/PI)
Equillium, Inc., Medpace Clinical Research LLC
7/17/24 → 7/17/27
Project: Research project
-
Prot #XL092-IST202/NU 23S03: A Single-Arm, Open-label Phase II Trial Testing the Activity of XL092 (Zanzalintinib) in Patients with Advanced Leiomyosarcoma
Pollack, S. M. (PD/PI)
7/16/24 → 7/16/27
Project: Research project